Scarica l'app Stockscreener
84.70
1.29%
1.08
Pre-mercato:
84.72
0.02
+0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$83.62
Aprire:
$83.25
Volume 24 ore:
5.89M
Relative Volume:
1.85
Capitalizzazione di mercato:
$40.27B
Reddito:
$5.83B
Utile/perdita netta:
$261.52M
Rapporto P/E:
156.22
EPS:
0.5422
Flusso di cassa netto:
$1.32B
1 W Prestazione:
+0.06%
1M Prestazione:
+3.41%
6M Prestazione:
+18.38%
1 anno Prestazione:
+24.27%
Intervallo 1D:
$82.70
$85.21
Intervallo di 1 settimana:
$79.37
$85.21
Portata 52W:
$61.76
$88.36
Ventas Inc Stock (VTR) Company Profile
Nome
Ventas Inc
Settore
Industria
Telefono
(312) 660-3800
Indirizzo
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, AHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
84.70 | 40.27B | 5.83B | 261.52M | 1.32B | 0.5422 |
WELL
Welltower Inc
|
210.00 | 147.95B | 10.83B | 961.84M | 2.11B | -0.7091 |
OHI
Omega Healthcare Investors Inc
|
46.67 | 13.90B | 1.20B | 609.47M | 810.60M | 1.9317 |
DOC
Healthpeak Properties Inc
|
16.20 | 11.26B | 2.82B | 100.19M | 1.15B | 0.1011 |
AHR
American Healthcare Reit Inc
|
50.32 | 9.65B | 2.27B | 70.82M | 165.88M | 0.4079 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | Goldman | Buy |
| 2025-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Iniziato | UBS | Neutral |
| 2025-06-23 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Iniziato | Deutsche Bank | Buy |
| 2024-01-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-11-07 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-10-11 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-10-03 | Iniziato | Wedbush | Neutral |
| 2023-09-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-06-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Iniziato | Wells Fargo | Overweight |
| 2022-11-01 | Reiterato | Credit Suisse | Outperform |
| 2022-11-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-23 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | CapitalOne | Overweight |
| 2022-05-18 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-02-01 | Iniziato | Credit Suisse | Neutral |
| 2022-01-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-12-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-11-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Ripresa | Mizuho | Neutral |
| 2021-06-15 | Iniziato | Wolfe Research | Outperform |
| 2021-06-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Aggiornamento | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Iniziato | Robert W. Baird | Neutral |
| 2020-11-30 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2020-11-10 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-09-08 | Downgrade | Argus | Buy → Hold |
| 2020-09-02 | Ripresa | Stifel | Hold |
| 2020-08-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Downgrade | Jefferies | Buy → Underperform |
| 2020-02-28 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-12-20 | Ripresa | Mizuho | Neutral |
| 2019-12-10 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2019-10-30 | Downgrade | Stifel | Buy → Hold |
| 2019-10-28 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Ventas Inc Borsa (VTR) Ultime notizie
BNP Paribas Adjusts Price Target on Ventas to $93 From $87, Maintains Outperform Rating - marketscreener.com
Ventas Announces Tax Treatment of 2025 Distributions - The National Law Review
Ventas (NYSE:VTR) Issues Quarterly Earnings Results, Beats Expectations By $0.82 EPS - MarketBeat
Here's What Key Metrics Tell Us About Ventas (VTR) Q1 Earnings - Yahoo Finance
Ventas Q1 2026 earnings preview - MSN
Ventas (VTR) Q1 FFO and Revenues Beat Estimates - Yahoo Finance
Ventas (NYSE:VTR) Releases FY 2026 Earnings Guidance - MarketBeat
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas (NYSE:VTR) Q1 2026: SHOP Boom Drives Beat, Guidance Hike Sends Shares Higher - ChartMill
National Health Investors is the most oversold real estate stock as Q1 earnings roll on - msn.com
Ventas Q1 Normalized FFO, Revenue Rises; Lifts Full Year Guidance - marketscreener.com
VENTAS ($VTR) Releases Q1 2026 Earnings - Quiver Quantitative
Ventas boosts full-year earnings guidance as occupancy gains fuel Q1 earnings beat (VTR:NYSE) - Seeking Alpha
Ventas: Q1 Earnings Snapshot - Barchart.com
(VTR) Ventas Expects 2026 Normalized FFO/Share Range $3.82-$3.89 - marketscreener.com
Ventas announces pricing of $500M senior notes offering - MSN
Earnings Flash (VTR) Ventas, Inc. Reports Q1 Revenue $1.66B, vs. FactSet Est of $1.59B - marketscreener.com
Ventas Reports 2026 First Quarter Results - The Joplin Globe
Ventas, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Ventas (VTR) Investor presentation Summary - Quartr
Ventas faces earnings test as senior housing boom accelerates By Investing.com - Investing.com Australia
Ventas faces earnings test as senior housing boom accelerates - Investing.com
Vanguard Group Inc. Acquires 2,349,176 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas Q3 FFO and Revenues Beat Estimates, Same-Store Cash NOI Rises - MSN
Earnings preview: What to expect from Ventas’ report - MSN
What's in the offing for Ventas stock this earnings season? - MSN
Ventas delivers modest Q4 earnings beat, issues strong guidance - MSN
Impax Asset Management Group plc Sells 29,585 Shares of Ventas, Inc. $VTR - MarketBeat
Teacher Retirement System of Texas Reduces Stock Holdings in Ventas, Inc. $VTR - MarketBeat
The Bull Case For Ventas (VTR) Could Change Following Upbeat Analyst Earnings RevisionsLearn Why - Sahm
Ventas Q4 2025 earnings preview - MSN
How Upbeat Earnings Revisions And Revenue Outlook At Ventas (VTR) Has Changed Its Investment Story - Yahoo Finance
A Look At Ventas (VTR) Valuation After Recent Share Price Momentum - simplywall.st
How Will Ventas Stock React To Its Upcoming Earnings? - Trefis
(VTR) Risk Channels and Responsive Allocation - Stock Traders Daily
BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $93 - 富途牛牛
VTR Earnings History & Surprises | EPS & Revenue Results | VENTAS INC (NYSE:VTR) - ChartMill
Ventas Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
M&T Bank Corp Buys 297,787 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Position Increased by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Ventas (VTR) Stock: Downside Risk Review (-2.14%) 2026-04-22Bollinger Bands - Xã Thanh Hà
Countdown to Ventas (VTR) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Ventas Inc. stock (US92276F1003): Is senior housing demand strong enough to unlock new upside? - AD HOC NEWS
Ventas, Inc. (NYSE:VTR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Ventas Inc (VTR) Stock Down 3.0% but Still Overvalued -- GF Score: 81/100 - GuruFocus
Ventas Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
What's in the Offing for Ventas Stock This Earnings Season? - TradingView
Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance
Land & Buildings Announces Investment Opinion: Issues White Paper Detailing Why It Believes Welltower’s Compensation Program Is Likely to Lead to Inferior Shareholder Returns - Business Wire
Mirae Asset Global Investments Co. Ltd. Raises Stake in Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. Common Stock (NYSE:VTR) Stock Quote - FinancialContent
Ventas Inc Azioni (VTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):